Yannis Bilquez, chairman of Charles Jourdan and of Avendis Capital, the Swiss-based investment company that took over the French brand of elegant footwear two years ago, cancelled a meeting with the shoe manufacturer’s staff, scheduled for Aug. 23 to give them an update on its negotiations to subcontract its production.
Your membership benefits:
If you aren’t ready to subscribe now, choose the 30 day trial for 1€. To continue reading this article REGISTER NOW.